Literature DB >> 20977541

The MRSA-import in ICUs is an important predictor for the occurrence of nosocomial MRSA cases.

B Schweickert1, C Geffers, T Farragher, P Gastmeier, M Behnke, T Eckmanns, F Schwab.   

Abstract

Nosocomial infections with methicillin-resistant Staphylococcus aureus (MRSA) account for increased morbidity, mortality and healthcare costs in critically ill patients worldwide. The intensive care unit (ICU) component of the German surveillance system for nosocomial infections (Krankenhaus-Infektions-Surveillance-System, KISS) has been supplemented with a module targeting the surveillance of multiresistant pathogens [Multiresistente Erreger (MRE)-KISS] in order to account for the increasing burden of antibiotic-resistant bacteria. The aim of this study was to assess the association between structural and organizational characteristics of ICUs and the number of nosocomial MRSA cases. Data were derived from routine data collected in the frame of the national surveillance system of nosocomial infections (ICU- and MRE-KISS) from January 2007 to December 2008 and from a questionnaire inquiring about structure and process parameters. One hundred and forty ICUs performing active screening have been included. Process parameters such as isolation of MRSA patients, decolonization procedures and introduction of MRSA alert systems have been implemented by the majority of the ICUs, whereas the application mode of screening procedures and pre-emptive isolation measures is heterogeneous. Multivariable analysis using negative binominal regression models shows that a stay on a medical ICU has a protective effect (incidence rate ratio, 0.42; 95% confidence interval, 0.24-0.74; p = 0.003), whereas the imported MRSA incidence is significantly associated with the number of nosocomial MRSA cases (incidence rate ratio, 1.74; 95% confidence interval, 1.23-2.45; p = 0.002). Structure and process parameters do not show any effect. ICU type and imported MRSA incidence should be considered for benchmarking between hospitals. 2010 The Authors. Clinical Microbiology and Infection; 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20977541     DOI: 10.1111/j.1469-0691.2010.03409.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  6 in total

1.  Evaluation of a disinfectant wipe intervention on fomite-to-finger microbial transfer.

Authors:  Gerardo U Lopez; Masaaki Kitajima; Aaron Havas; Charles P Gerba; Kelly A Reynolds
Journal:  Appl Environ Microbiol       Date:  2014-03-07       Impact factor: 4.792

2.  MRSA-surveillance in Germany: data from the Antibiotic Resistance Surveillance System (ARS) and the mandatory surveillance of MRSA in blood.

Authors:  B Schweickert; I Noll; M Feig; H Claus; G Krause; E Velasco; T Eckmanns
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

3.  Controlling emerging zoonoses at the animal-human interface.

Authors:  Riley O Mummah; Nicole A Hoff; Anne W Rimoin; James O Lloyd-Smith
Journal:  One Health Outlook       Date:  2020-09-18

4.  Screening and control of methicillin-resistant Staphylococcus aureus in 186 intensive care units: different situations and individual solutions.

Authors:  Anke Kohlenberg; Frank Schwab; Michael Behnke; Christine Geffers; Petra Gastmeier
Journal:  Crit Care       Date:  2011-11-25       Impact factor: 9.097

Review 5.  Multiresistant bacteria and current therapy - the economical side of the story.

Authors:  Michael H Wilke
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

6.  Individual units rather than entire hospital as the basis for improvement: the example of two Methicillin resistant Staphylococcus aureus cohort studies.

Authors:  Petra Gastmeier; Frank Schwab; Iris Chaberny; Christine Geffers
Journal:  Antimicrob Resist Infect Control       Date:  2012-02-13       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.